等待开盘 11-11 09:30:00 美东时间
-0.270
-0.76%
今日重点评级关注:花旗:维持Caribou Biosciences"买入"评级,目标价从5美元升至8美元;HC Wainwright & Co.:上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入",目标价30美元
11-04 10:31
今日重点评级关注:康托·菲茨杰拉德:维持Cabaletta Bio"超配"评级,目标价从15美元升至30美元;HC Wainwright & Co.:维持Invivyd"买入"评级,目标价从5美元升至10美元
11-03 20:20
Evercore ISI Group analyst Jonathan Chappell maintains Hub Group (NASDAQ:HUBG) with a In-Line and raises the price target from $37 to $38.
10-31 21:20
Hub Group (NASDAQ:HUBG) narrows FY2025 GAAP EPS guidance from $1.80-$2.05 to $1.80-$1.90 vs $1.83 analyst estimate. Narrows FY2025 sales outlook from $3.600 billion-$3.800 billion to $3.600 billion-$3.700 billion vs
10-31 04:09
Hub Group (NASDAQ:HUBG) reported quarterly earnings of $0.49 per share which met the analyst consensus estimate. This is a 5.77 percent decrease over earnings of $0.52 per share from the same period last year. The
10-31 04:09
Companies Reporting Before The Bell • Altria Group (NYSE:MO) is projected to re...
10-30 19:12
Essendant, a leading national wholesale distributor, today announced a strategic partnership with Hub Group to implement its Managed Delivery model, a cornerstone of Essendant's New Way Forward supply chain
10-24 21:08
今日重点评级关注:摩根士丹利:上调Alvotech评级至"超配",目标价14美元;蒙特利尔银行:维持PG&E"跑赢大市"评级,目标价从23美元升至25美元
10-15 18:20
今日重点评级关注:摩根大通:维持National Energy Services"超配"评级,目标价从10美元升至19美元;Piper Sandler:维持LENZ Therapeutics"超配"评级,目标价从51美元升至67美元
10-13 11:26
10 analysts have shared their evaluations of Hub Group (NASDAQ:HUBG) during the...
10-11 02:00